(1) In the October issue of European Heart Journal – Cardiovascular Pharmacotherapy, Dr Dellborg and co-workers report the efficacy and safety in the subpopulation recommended for treatment in ...
ORION-11 included 1,617 patients with atherosclerotic cardiovascular disease (ASCVD), or ASCVD risk equivalents, and elevated LDL-C despite maximally tolerated statins (with or without ...
Workload adjusted blood pressure response rather than peak systolic blood pressure is associated with increased all-cause mortality in males; results from 7097 treadmill exercise tests
The impact of stress myocardial blood flow as a very strong predictor for all-cause mortality, cardiovascular mortality and adverse cardiac and cerebrovascular event in hemodialysis population.
Uric acid visit-by-visit variability is an independent risk factor of CHD- and all-cause mortality
High risk plaque by coronary CTA predict cardiac events but not all-cause mortality: long term follow up
The impact of patient's adherence to maintenance of euvolaemia on all-cause mortality and heart failure re-hospitalization: insights from the Optimize Heart Failure Care Program
Coronary artery calcification predicts MACE and all-cause mortality in individuals undergoing non-cardiac computed tomography for non-cardiovascular indications
HDL-C and all-cause mortality in a high-risk population: impact of LDL-C
Gender differences in long-term outcomes and predictors of all-cause mortality after percutaneous coronary intervention.